VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$16.47
-0.78 (-4.52%)
As of May 16, 2:02 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +110.9% upside
Low Target $25.90
Average Target $34.74
High Target $38.60
Current Price $16.47
Current
$16.47
Target
$34.74
$25.90 $34.74 avg $38.60
Scenario Analysis
Bear Case
$25.90
57.3%
Low target
Base Case
$34.74
+110.9%
Avg target
Bull Case
$38.60
+134.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$65.80
-75.0% from high
52-Week Low
$3.06
+438.2% from low
Target vs 52W High
$34.74
-47.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%